Seven Eight Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,824
| Closed | -$1.67M | – | 703 |
|
|
2024
Q1 | $1.67M | Buy |
4,824
+1,972
| +69% | +$682K | 0.17% | 176 |
|
|
2023
Q4 | $921K | Buy |
2,852
+675
| +31% | +$218K | 0.11% | 277 |
|
|
2023
Q3 | $780K | Buy |
+2,177
| New | +$780K | 0.09% | 301 |
|
|
2022
Q2 | – | Sell |
-1,081
| Closed | -$609K | – | 394 |
|
|
2022
Q1 | $609K | Buy |
+1,081
| New | +$609K | 0.08% | 288 |
|
|
2019
Q2 | – | Sell |
-2,459
| Closed | -$752K | – | 582 |
|
|
2019
Q1 | $752K | Buy |
+2,459
| New | +$752K | 0.04% | 396 |
|
|
2017
Q4 | – | Sell |
-2,500
| Closed | -$556K | – | 455 |
|
|
2017
Q3 | $556K | Buy |
2,500
+2,300
| +1,150% | +$512K | 0.07% | 330 |
|
|
2017
Q2 | $45K | Sell |
200
-6,800
| -97% | -$1.53M | 0.01% | 489 |
|
|
2017
Q1 | $1.4M | Buy |
7,000
+5,500
| +367% | +$1.1M | 0.27% | 132 |
|
|
2016
Q4 | $273K | Buy |
+1,500
| New | +$273K | 0.05% | 369 |
|